New depression pill shows promise in early trial
NCT ID NCT06309277
First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 24 times
Summary
This study tested a new oral medication, GM-1020, in 46 adults with major depressive disorder. The goal was to check safety and see if it can quickly improve mood. Researchers measured side effects and depression scores over 24 hours to assess the drug's potential.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
MAC Clinical Research
Manchester, United Kingdom
Conditions
Explore the condition pages connected to this study.